Literature DB >> 20465498

miRNAs as molecular biomarkers of cancer.

Muller Fabbri1.   

Abstract

miRNAs are noncoding RNAs that regulate gene expression. The advent of high-throughput techniques has revealed that miRNA expression is deregulated in almost all human tumors (both solid and hematologic) with respect to the normal tissue counterpart. These differences frequently recur in tumor-specific miRNA signatures, which are very helpful to diagnose the tissue of origin of the neoplasia, and sometimes also specific tumor subtypes. Increasing evidence also supports a role for miRNAs as prognostic biomarkers of human cancers. Finally, miRNAs are differentially expressed in the blood of cancer patients versus healthy donors, providing a rationale for the detection of miRNAs and diagnostic and prognostic circulating biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465498     DOI: 10.1586/erm.10.27

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  45 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

2.  Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTEN.

Authors:  Qi Xue; Kai Sun; Hai-Jun Deng; Shang-Tong Lei; Jing-Qing Dong; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 4.  DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Authors:  Yuji Toiyama; Yoshinaga Okugawa; Ajay Goel
Journal:  Biochem Biophys Res Commun       Date:  2014-08-13       Impact factor: 3.575

Review 5.  Sizing up the future of microRNA analysis.

Authors:  Abraham J Qavi; Jared T Kindt; Ryan C Bailey
Journal:  Anal Bioanal Chem       Date:  2010-08-01       Impact factor: 4.142

6.  Small RNA profiling reveals phosphorus deficiency as a contributing factor in symptom expression for citrus huanglongbing disease.

Authors:  Hongwei Zhao; Ruobai Sun; Ute Albrecht; Chellappan Padmanabhan; Airong Wang; Michael D Coffey; Thomas Girke; Zonghua Wang; Timothy J Close; Mikeal Roose; Raymond K Yokomi; Svetlana Folimonova; Georgios Vidalakis; Robert Rouse; Kim D Bowman; Hailing Jin
Journal:  Mol Plant       Date:  2013-01-05       Impact factor: 13.164

7.  miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened.

Authors:  Kai Sun; Hai-Jun Deng; Shang-Tong Lei; Jing-Qing Dong; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 8.  Data submission and quality in microarray-based microRNA profiling.

Authors:  Kenneth W Witwer
Journal:  Clin Chem       Date:  2013-02       Impact factor: 8.327

Review 9.  MicroRNAs: potential mediators and biomarkers of diabetic complications.

Authors:  Mitsuo Kato; Nancy E Castro; Rama Natarajan
Journal:  Free Radic Biol Med       Date:  2013-06-12       Impact factor: 7.376

Review 10.  MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.